Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022
The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 - 2022 report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies
The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report.
This report provides details of the latest manufacturing and supply agreements announced in the pharmaceutical, biotechnology, device and diagnostic sectors. Fully revised and updated, the report provides details of manufacturing and supply agreements from 2015 to 2022.
The report provides a detailed understanding and analysis of how and why companies enter manufacturing and supply deals.
A supply or manufacturing agreement is normally between a product manufacturer and product owner in which an owner outsources the manufacture and supply of its product(s) to the service company in a defined territory.
Manufacturing and supply agreements provide a popular method of maximizing the value of a product launched into a market. The deals allow the product marketer to focus on its sales and marketing efforts whilst relying on a third party to manufacture and supply product on demand, enabling rapid response to market demands. It also ensures that the marketer does not need to invest in costly infrastructure and expertise ahead of knowing whether the product will be successful or sustainable.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of manufacturing and supply deals announced since 2015 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual manufacturing and supply contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
The initial chapters of this report provide an orientation of manufacturing and supply deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in manufacturing and supply deal making as well as a discussion on the merits of the type of deal.
Chapters 3 and 4 provide an overview of the structure of manufacturing and supply deals. The chapter includes numerous case studies to enable understanding of both pure manufacturing and supply deals and multicomponent deals where manufacturing and supply forms a part.
Chapter 5 provides a review of the leading manufacturing and supply deals since 2015. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 6 provides a review of the top 25 most active biopharma companies in manufacturing and supply. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 7 provides a comprehensive and detailed review of manufacturing and supply deals signed and announced since 2015 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.
The report also includes numerous table and figures that illustrate the trends and activities in manufacturing and supply deal making since 2015.
In addition, a comprehensive appendix is provided organized by manufacturing and supply company A-Z, stage of development, therapeutic target, technology type and deal type definitions. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about manufacturing and supply partnering in the research, development and commercialization of technologies and products.
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 provides the reader with the following key benefits:
- In-depth understanding of manufacturing and supply deal trends since 2015
- Analysis of the structure of manufacturing and supply agreements with real life case studies
- Comprehensive access to actual manufacturing and supply deals entered into by the world’s biopharma companies
- Detailed access to actual manufacturing and supply deals entered into by the leading twenty five bigpharma companies
- Comprehensive access to all manufacturing and supply deals entered since 2015
- Insight into the terms included in a manufacturing and supply agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 is intended to provide the reader with an in-depth understanding of the manufacturing and supply trends and structure of deals entered into by pharma, biotech, device and diagnostics companies worldwide.
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 includes:
- Trends in manufacturing and supply dealmaking in the biopharma industry since 2015
- Analysis of manufacturing and supply deal structure
- Case studies of real-life manufacturing and supply deals
- Access to manufacturing and supply deal records covering pharma, biotech, devices and diagnostics since 2015
- The leading manufacturing and supply deals by value since 2015
- Most active manufacturing and supply dealmakers since 2015
- The leading manufacturing and supply partnering resources
In Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022, the available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Therapeutic area
- Technology type
Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides comprehensive access to available records for maufacturing and supply deals, including contract documents where available. Analyzing actual contract agreements allows assessment of the following:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides the reader with the following key benefits:
- In-depth understanding of manufacturing and supply partnering deal trends since 2015
- Insight into the terms included in a manufacturing and supply agreement, together with real world clause examples
- Identify leading manufacturing and supply deals by value since 2015
- Identify the most active manufacturing and supply dealmakers since 2015
- Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
- Full listing of manufacturing and supply deals by company A-Z, deal value, phase of development, deal type, therapy and technology focus
- Comprehensive access to manufacturing and supply deals entered into by the world’s biopharma companies, together with contract documents if available
- Detailed access to actual manufacturing and supply contracts entered into by the leading twenty five big pharma and big biotech companies
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Chapter 1 – Introduction
Chapter 2 – Trends in manufacturing and supply deal making
2.2. Difference between manufacturing and supply deals
2.3. Trends in manufacturing and supply deals since 2015
2.3.1. Manufacturing and supply deal making by year since 2015
2.3.2. Manufacturing and supply deal making by phase of development since 2015
2.3.3. Manufacturing and supply deal making by industry sector since 2015
2.3.4. Manufacturing and supply deal making by therapy area since 2015
2.3.5. Manufacturing and supply deal making by technology type since 2015
2.3.6. Manufacturing and supply deal making by most active company since 2015
2.3.7. When supply can be useful
2.4. Attributes of pure manufacturing and supply deals
2.5. Attributes of manufacturing and supply in multi-component deals
2.6. Reasons for including manufacturing and supply options in a multi-component deal
2.7. The future of manufacture and supply as part of multicomponent deals
Chapter 3 – Overview of manufacturing and supply deal structure
3.2. Pure versus multi-component manufacturing deals
3.3. Pure manufacturing agreement structure
3.3.1. Example manufacturing agreements
3.3.1.a. Case study 1
3.3.1.b. Case study 2
3.4. Manufacturing rights as part of a wider alliance agreement
3.4.1. Example multicomponent manufacturing clauses
3.4.1.a. Case study 3
3.4.1.b. Case study 4
Chapter 4 – Overview of supply deal structure
4.2. Supply agreement structure
4.2.1. Example supply agreements
4.2.1.a. Case study 5
4.2.1.b. Case study 6
4.3. Supply rights as part of a wider alliance agreement
4.3.1. Example co-marketing right clauses
4.3.1.a. Case study 7
4.3.1.b. Case study 8
Chapter 5 – Leading manufacturing and supply deals
5.2. Top manufacturing and supply deals by value
Chapter 6 – Top 25 most active manufacturing and supply dealmakers
6.2. Top 25 most active manufacturing and supply dealmakers
Chapter 7 – Manufacturing and supply deals contract directory since 2015
7.2. Manufacturing and supply deals with contracts since 2015
Appendix 1 – Manufacturing and supply deals by company A-Z
Appendix 2 – Manufacturing and supply deals by stage of development
Appendix 3 - Manufacturing and supply deals by deal type
Appendix 4 – Manufacturing and supply deals by therapy area
Appendix 5 – Manufacturing and supply deals by technology type
Appendix 6 – Deal type definitions
About Wildwood Ventures
Recent report titles from Current Partnering
TABLE OF FIGURES
Figure 1: Definition of manufacturing and supply
Figure 2: Types of manufacturing agreement
Figure 3: Trends in manufacturing and supply deal announcements since 2015
Figure 4: Manufacturing and supply deals signed at each phase of development since 2015
Figure 5: Manufacturing and supply deals by industry sector since 2015
Figure 6: Manufacturing and supply deals by therapy area since 2015
Figure 7: Manufacturing and supply deals by technology type since 2015
Figure 8: Top 25 most active manufacturing and supply dealmakers since 2015
Figure 9: Components of the manufacturing deal structure
Figure 10: Components of the supply deal structure
Figure 11: Top manufacturing and supply deals by value since 2015
Figure 12: Most active manufacturing and supply dealmakers since 2015
- $3,995: single-user
- $5,745: multi-user
- $10,995: single site license
- $17,995: global site license
A full explanation of license type definitions can be found here.
We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.
We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)
If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.
All card payments are processed by SagePay.
If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.
- Total Trust
Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.
2BScientific, 3 Rivers Biotech, 3D Systems, 3M, 3P Biopharmaceuticals, 4D Pharma, 10X Genomics, 22nd Century, 48North Cannabis, 111, 180 Life Sciences, 908 Devices, aaiPharma, AAIPharma Services, AavantiBio, AB2 Bio, Abacus International, Abaxis, Abba Medix, ABB Optical Group, Abbott Laboratories, Abbott Rapid Diagnostics, Abbott Vascular Devices, Abbvie, Abcam, Abcuro, ABEC, Abeona Therapeutics, Abingdon Health, Abiomed, ABL Bio, Abogen Biosciences, Abracon, Abzena, Academy Medical, Accelerate Diagnostics, Acceleron Pharma, Accellta, Access BIO, Access Vascular, Accinov, Accord Healthcare, Accuray, Accu Reference Medical Laboratory, Acelity, Acell, Acelrx Pharmaceuticals, Acer Therapeutics, Acerus, Achieve Life Science, Acino Pharma, Acnos Pharma, Acon Labs, Acorda Therapeutics, Activhealth, Actym Therapeutics, Acutus Medical, Adagene, Adagio Therapeutics, AdAlta, Adaptimmune, Adaptive Phage Therapeutics, Adapt Pharma, AdaptVac, Adherium, Adhesys Medical, Adial Pharmaceuticals, Adisseo, Adjupharm, ADL Bionatur Solutions, ADM Tronics, Advanced Accelerator Applications, Advanced Animal Diagnostics, Advanced BioScience Laboratories, Advanced Dermatology and Cosmetic Surgery Group, Advanced Extraction Systems, Advanced Flow Systems, Advanced Human Imaging, Advanz Pharma, Advent International, Aegea Biotechnologies, Aeglea BioTherapeutics, Aerami Therapeutics, Aerie Pharmaceuticals, Aerogen, Aesculap, AEterna Zentaris, Aethlon Medical, Aetna, Affinia Therapeutics, AFT Pharmaceuticals, Agappe, AGC Biologics, Agena Bioscience, Agenus Bio, AgeX Therapeutics, Agfa HealthCare, Aggrega Pharma, Agilent Technologies, Agilis Biotherapeutics, Agiomix FZ, AgMedica Bioscience, AgraFlora Organics International, Agro-Greens Natural Products, Agroresults, AGTC, Aimmune Therapeutics, AIM Plastics, Aires Pharmaceuticals, Ajinomoto, Ajinomoto Bio-Pharma Services, AJU Pharma, AkaRx, Akers Biosciences, Akron Biotechnology, Akston Biosciences, Akula Trading 2 Pty, Akums Drugs and Pharmaceuticals, Albany Molecular Research, Alberta Cell Therapy Manufacturing, Alberta Health Services, Albert Einstein Healthcare Network, Albumedix, Alcami, Alcon Laboratories, Alcove Manufacturing and Distribution, Aldevron, Aleafia Health, Alexion Pharmaceuticals, Alexza Pharmaceuticals, Alfasigma, Algae Dynamics, Algernon Pharmaceuticals, ALK-Abello, Allarity Therapeutics, AllCells, Allcure Kangtai Proton Technology, Allecra Therapeutics, Allegheny General Hospital, Allegheny Technologies, Allergan, Allied Corp, Alligator Bioscience, Alliqua Biomedical, Almac Diagnostics, Almelo, Alnylam Pharmaceuticals, Alpha Genesis, Alpha Imaging, Alphamab Biopharmaceuticals, Alphatec Spine, Alphazyme, Alpine Immune Sciences, ALR Technologies, Alseres Pharmaceuticals, Altamira Bio, Altasciences, Altimmune, Altopa, Alverno Clinical Laboratories, Alvit LCS Pharma, Alvogen, Alvotech, AM-Pharma, Amag Pharmaceuticals, Amaran Biotechnology, Amasa Therapeutics, Amazon Web Services, Ambiopharm, Ambu, AmCad BioMed, AM Chemicals, Amedica, America's Choice Provider Network, American Academy of Implant Dentistry Foundation, American Oncology Network, American Regent, American Society for Aesthetic Plastic Surgery, American Well, Amerinet, AmerisourceBergen, Amgen, Amgros, AMI, Amicrobe, Amicus Therapeutics, Amneal Pharmaceuticals, AMNIOX, AmpTec, AMRA Medical, AMRI Hungary, AMS, AMSilk, Amyris, Analytical Biological Services, ANA Therapeutics, ANI Pharmaceuticals, Annoroad, ANP Technologies, Ansun Biopharma, Antares Pharma, Antengene, Anthem, Anthem Bluecross, Anthony Nolan, AOTI, Apceth, Aphria, Apicore, Apipharm Veletrgovina, APL, Apollo Green, Apollo Hospitals Group, Apollomics, Apollon Formularies, Apotex, Appian Labs, Appili Therapeutics, Apple, Applied BioCode, Applied DNA Sciences, Applied Microarrays, Applied Pharmaceutical Innovation, Aprecia Pharmaceuticals, APRINOIA Therapeutics, Apsen Farmacutica, APS Healthcare, Aptahem, Aptar CSP Technologies, AptarGroup, Aptar Pharma, Aptevo Therapeutics, Aquestive Therapeutics, Aralez Pharmaceuticals, Aratana Therapeutics, Aravive Biologics, ARaymondlife, ARCA Biopharma, Arch Biopartners, Archer Daniels Midland Company, ArcherDX, Arch Oncology, Arch Pharmalabs, Arch Therapeutics, Arcturus Therapeutics, Arcus Therapeutics, Arena Pharmaceuticals, Argentia Gold, Argonaut, Argonaut Manufacturing Services, Argos Therapeutics, ArisGlobal, Arjo, Ark Biosciences, Arkema, Arkray USA, Arla Foods, Armor, Aronora, Arrow Pharmaceuticals, Arsenal Medical, Artes Biotechnology, ARTMS Product, Art of Technology, ARUP Laboratories, Aruvant Sciences, Arzeda, Asahi Intecc, Asahi Kasei Kuraray Medica, Ascendance Biotechnology, Ascensia Diabetes Care, Ascentage Pharma, Ascletis, ASC Therapeutics, Asensus Surgical, Asher Biotherapeutics, Asian Eye Institute, AskAt, ASM International, Aspen Global, Aspen Holding, ASPiRA Labs, Aspyrian Therapeutics, ASR Group, Astellas Pharma, Asterias Biotherapeutics, AstraZeneca, Astute Medical, Asymchem Laboratories, Asys, Atara Biotherapeutics, Atbtherapeutics, AtCor Medical, Athenex, Athersys, Atlas Antibodies, Atomo Diagnostics, Atonarp, Atossa Therapeutics, Attana, aTyr Pharma, Aucta Pharmaceuticals, AudioNova, AUM Biotech, Aura Biosciences, Aurena Laboratories, Aurigene Discovery Technologies, Aurinia Pharmaceuticals, Auris Health, Aurobindo Pharma, Aurora Cannabis, Australian Nuclear Science and Technology Organisation, Autogen, AutoGenomics, Automated Systems of Tacoma, Auxly Cannabis Group, Avacta, Avanos Medical, Avaria Health & Beauty, AV Cannabis, Avella, Avellino Labs, AVEO Oncology, Avera McKennan, Avery Therapeutics, AveXis, Avicanna, Avid Bioservices, Avista Pharma Solutions, Avita Medical MENA, Avitide, Avrio Biopharmaceuticals, AXIM Biotechnologies, Axiom Worldwide, Axonics Modulation Technologies, Axovant Gene Therapies, Axxess Pharma, Aytu BioPharma, Azellon Cell Therapeutics, Aziyo Biologics, AzurRx BioPharma, Azzur Group, Bachem, BAMF Health, Banc De Sang I Teixits, Banfield Pet Hospital, BANYAN Medical Systems, Baoding Med-Joy Medical, BASF, Basilea Pharmaceutica, Batavia Biosciences, Battelle, Bausch & Lomb, Bavarian Nordic, Baxter International, Bayer, Bayer Healthcare, Baylor College, Baylor College of Medicine, Baylor Genetics, BayMedica, Bazelet, BBI Solutions, BC Platforms, Beckman Research Institute of City of Hope, Becton Dickinson, BeiGene, Beike Biotech, Beleave, Belimed, Bellerophon Therapeutics, Bellicum Pharmaceuticals, Benchmark Electronics, Bendalis, Bened Biomedical, Benitec Biopharma, Benvenue Medical, Berkeley Lights, Berkshire Sterile Manufacturing, Berlin Chemie, Beroni Group, Best Supplies, Be The Match BioTherapies, Bethyl Laboratories, BetterLife Pharma, BevCanna, Beyond Air, Bharat Biotech, Bial, BIA Separations, Bigfoot Biomedical, Bill and Melinda Gates Foundation, BillionToOne, Binex, Bio-Manguinhos, Bio-Manguinhos/Fiocruz, Bio-Rad Laboratories, Bio-Techne, Bio-Thera Solutions, BioAmber, biOasis Technologies, BioCentriq, Biocept, BioChain, BioCheck, BioClinica, Biocon, BIOCORP, BioCorRx, Biodesix, Biodextris, BioDuro, BioEleven, BioElpida, Biogen, BioGeneration Ventures, BioGX, Biohit Healthcare, BioInvent, BioIQ, Biokinetic Europe, BioLamina, Biolase, BioLife Solutions, BioLight, Biolog-id, Biological E, Biologics, BioM, Biomedical Advanced Research and Development Authority, Biomerics, Bionik Laboratories, BioNTech, BioPharma Services, Biophore Pharmaceuticals, Bioprojet, Bioptic, BioQ Pharma, Bioqube Ventures, BioReliance, Bioretec, Biosafe, Bioscience Enterprises, BioSig Technologies, BioSkryb, BioSpherix, BioSpring, BioStem Life Sciences, BioStem Technologies, BioSun Pharmed, BioSurfaces, BioSyent Pharma, Biotalys, BioTechnique, Biotechnology Innovation Organization, BioTelemetry, BioTrackTHC, Biotropical, Biovac, BioVaxys, BioVectra, BioVest, BioXpress, Birdie Biopharmaceuticals, BiVictriX Therapeutics, BJ Bioscience, BJC HealthCare, BKK Mobil Oil, BL&H, BLLRDR, Blood Bank Of Delmarva, Blood Centers of America, Blood Systems, Bluebird Bio, Bluechiip, Blue Cross Blue Shield Association, BlueCross BlueShield of Tennessee, Blue Earth Diagnostics, BlueJay Therapeutics, Blue Water Vaccines, BMG Pharmaceuticals, Bode Technology, Boehringer Ingelheim, Bolt Biotherapeutics, Bone Bank Allografts, Bone Biologics, Bone Therapeutics, Bonfils Blood Center, Bonify, Bonne Santé Group, Bonus BioGroup, Bophelo Bioscience & Wellness, Bora Pharmaceuticals, Boreal Genomics, Bosch, Boston Pharmaceuticals, Boston Scientific, BostonSight, BoTEC Medical, Bovie Medical, Box, Bracco Diagnostics, Bracco Imaging, Braeburn Pharmaceuticals, BrainStorm Cell Therapeutics, Brainsway, Brammer Bio, Breckenbridge Pharmaceutical, Breckenridge Pharmaceuticals, BridgeBio Pharma, Brigham and Women's Hospital, Bristol-Myers Squibb, British Columbia Liquor Distribution Branch, BRIT Systems, BRNT, Bruce Power, Bruker, Bruker AXS, Bryn Pharma, BryoLogyx, BSN Medical, BSP Pharmaceuticals, BTG, Buoy Health, Burke Therapeutics, Burleigh Heads Cannabis, Burton Hospitals NHS Foundation Trust, Bushu Pharmaceuticals, Butantan Institute, BWXT Medical, C&C Irradiator Service, C-RAD, C3i, Caffeluxe, Caladrius Biosciences, Caliber Biotherapeutics, California Institute of Technology, Caliva, Calmare Therapeutics, Calypso Biotech, Calysta Energy, Camber Pharmaceuticals, Cambrex, Cambridge Clinical Laboratories, Cambridge Isotope Laboratories, Cambridge Major Laboratories, Canada House Wellness Group, Canadian Blood Services, Canadian Nuclear Laboratories, CANbridge Pharmaceuticals, Cancer Genetics, Cancer Research UK, Cannabics Pharmaceuticals, Cannabis Global, Cannabis Medical Solutions, Cannabis Suisse, CannaCure, CannaHive, Cannamedical Pharma, Cannatrek Medical, Canndeo, Cannim Australia, CanniMed Therapeutics, Canntab Therapeutics, CannTrust, Cannus Partners, Canon, Canonic, Canon Virginia, Canopy Growth, CanSinoBIO, Cantargia, Cantek, Canymed, Capcium, Capital Brands, Capna Intellectual, Capstone Health Alliance, Cardinal Health, CardioDx, CardioGenics, Cardiome Pharma, CardioNavix, Cardiovascular Systems, CareDx, Carestream Health, CareTaker Medical, Caretta Therapeutics, Carisma Therapeutics, Carl Zeiss, CaroGen, CarThera, Cascade Chemistry, CASI Pharmaceuticals, CAS Medical Systems, Cassava Sciences, Cassiopea, Castle Biosciences, CasZyme, Catalent, Catalyst Pharmaceuticals, Cataract & Laser Institute, CBL Patras, CB Therapeutics, CC Pharma, CDx Diagnostics, CEA-Leti, Cediprof, Celcuity, Celgene, Celladon, Cell and Gene Therapy Catapult, Cell Applications, Cellarity, Cellastra, Cellectar Biosciences, Cellectis, Cellectricon, Cellevolve Bio, Cell Guidance Systems, Cell Point, Cell Signaling Technology, Celltheon, Cell Therapy Catapult, Celltrion, Cellular Biomedicine, Cellular Dynamics International, Cellular Goods, Cellumed, Celonic, CeloNova BioSciences, Celsee, Celsion, Celularity, Celyad, CEM, Cenexi, Center for Neurorestoration and Neurotechnology, Central Association for the Blind and Visually Impaired, Central California Blood Center, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Probe Development and Commercialization, Centric Health Resources, Cepheid, Cerapedics, Cereal Ingredients, Ceres, Cerevast Therapeutics, Certis, Cerus, Cerveau Technologies, Cesca Therapeutics, Cevec Pharmaceuticals, cGreen, Champion Healthcare, Changshan Pharm, Chargeurs, Charles River Laboratories, Chart Industries, CHC Healthcare group, Check-Cap, Checkmate Pharmaceuticals, Checkpoint Therapeutics, Cheetah Medical, Chembio Diagnostics, Chemesis, ChemGenes, Chemical Abstracts Service (CAS), Chemomab Therapeutics, ChemRar High-Tech Center, Chemveda Life Sciences, ChemWerth, Chiasma, Chiesi Farmaceutici, Children's Hospital Boston, Children's Mercy Hospital, Chime Biologics, China Biologic Products, China Grand Pharmaceutical, China Isotope And Radiation, Chiome Bioscience, Choctaw-Kaul, Chongqing Lummy Pharma, Chr Hansen, Christus Health, ChromaDex, Chugai Pharmaceutical, Chung Shan Medical University Hospital, Cigna Healthcare, Cincinnati Children’s Hospital Medical Center, Cipher Pharmaceuticals, Cipla, CIRCA Scientific, Circassia, Cirrus Dx, Citrine Medicine, Civica Rx, CJ CheilJedang, CJ Corp, Claremont BioSolutions, Clarity Pharmaceuticals, Cleaning Services Global, Clean Republic, ClearMask, Cleveland Clinic, Cleveland University Hospitals, Clinical Genomics, Clinigen, Clover Biopharmaceuticals, Clovis Oncology, CMAB Biopharma, CMC Biologics, CNS Pharmaceuticals, Co-Diagnostics, Coala Life, Coalition for Epidemic Preparedness Innovations, Cobra Biologics, Codagenix, Codex DNA, Codexis, Codiak BioSciences, Coeptis Pharmaceuticals, Cogmedix, Cognate BioServices, Cohealo, CoImmune, Colep, Collaborative Drug Discovery, Collagen Solutions LLC, Collagen Solutions Plc, Collplant, Colorado HealthOP, Color Genomics, Columbia University, CombiGene, ComDel Innovation, Comercializadora BioRenal, Comet Biorefining, Commonwealth Laboratories, Companhia Energetica Integrada, Compumedics, Confluent Medical Technologies, ConforMIS, Consilient Health, Consort Medical, Contextual Genomics, CONTINUUS Pharmaceuticals, Control Flo Medical, Convergent Therapeutics, Cook Biotech, Copan Diagnostics, CORAT Therapeutics, Cord Blood Registry, Corden Pharma, CoreRx Pharma, Cornerstone Healthcare Group, Corning, Correvio Pharma, CorTechs Labs, CorVent Medical, Corza Health, Cosmo Pharmaceuticals, Covalon Technologies, COVAX, COVAXX, Covestro, Covetrus, Coyne Healthcare, CreaGen Biosciences, Cream of the Crop Therapeutics, Creoptix, Crescita Therapeutics, Cresset, Crestar Labs, CRISPR Therapeutics, CROMA Pharma, Cronos Group, Crop Infrastructure, Crossbeta Biosciences, Crossject, Crown Laboratories, Cryolife, CryoPort, CRYO Science, CrystalGenomics, CSL, CSL Behring, CTSI Oncology Solutions, Cummins, CureCell, CURE Pharmaceutical, Curetis, CureVac, Curia, Curtana Pharmaceuticals, CutisPharma, CVR Global, CVS Pharmacy, CyanVac, Cyclacel Pharmaceuticals, Cyclotek, CyDex, Cygnus, Cyient, Cynata Therapeutics, Cyndea Pharma, Cytiva, Cytodyn, CytoSen Therapeutics, CytoSMART Technologies, Cytovance Biologics, Cytovant Sciences, Cytovation, CYTOVIA Therapeutics, Cyxone, Daavlin, Daewoong Pharmaceutical, Daiichi Sankyo, Dako, Dalton Pharma Services, Dana-Farber Cancer Institute, DarioHealth, DaVita, DCPrime, Debiopharm, Decibel Therapeutics, Decision Diagnostics, Dectris, Deep Lens, Defense Advanced Research Projects Agency, Defense Logistics Agency, Degania Silicone, Delpharm, Delta, Demetrix, Denali Therapeutics, Dendreon, Department of Defense, Department of Energy, Department of Health and Human Services, Department of Veterans Affairs, Dermapharm, Derma Sciences, DermTech, Designs for Health, Devonian Health Group, Dexcel Pharma, diaDexus, Diamond Light Source, Dignitana, DisperSol Technologies, Distributed Bio, Diverchim, Dizal Pharmaceutical, DKSH, DKT, DMDmodular, DNAmito, DnaNudge, Dominion Aesthetic Technologies, Dong-A ST, DONG Energy, Dosecann, Dove Professional Apparel, Dow Chemical, Dow Pharmaceutical Sciences, Dr. Reddy's Laboratories, Dr Bragi Company, Drugs for Neglected Diseases Initiative, DSG, DSM, DSM Nutritional Products, Duchesnay, Dutch Passion Seed Company, Dutch SAZ, DWK Life Sciences, Dyadic International, DyDo Pharma, Dynamic Blending, Dynavax Technologies, DYNEX Technologies, DySIS Medical, Eastern Capital, Eastern Ontario Regional Laboratory Association, Echolight Medical, Echosens, Ecomed Solutions, Eczacıbasi-Monrol, EDAP TMS, Eddingpharm, Edenbridge Pharmaceuticals, EDF, Edge Pharma, Edico Genome, Edison Nation, Editas Medicine, eFFECTOR Therapeutics, EirGenix, Eirion Therapeutics, EirMed, Eisai, Eisai Inc, Eitan Group, Elanco, Elanix Biotechnologies, Elation Health, Electrical Geodesics, Elekta, Elemaster Group, Elevar Therapeutics, ElevateBio, Eli Lilly, Elite Pharmaceuticals, Ellume, ElMindA, EluSys Therapeutics, Emcure Pharmaceuticals, EMD Millipore, Emerald Health Therapeutics, Emergent BioSolutions, Emergex Vaccines, Empowered Diagnostics, Enable Injections, Enamine, Encision, Enclara Pharmacia, Encompass, EndoCeutics, Endocyte, Endo International, Endomag, Endo Pharmaceuticals, Endo Ventures, endpoint Clinical, Endpoint Health, Engage Therapeutics, Engineered Medical Solutions, Ensysce Biosciences, Entera Health, Enteris Biopharma, Enthusiasmus, Entos Pharmaceuticals, Entourage Phytolab, Entrinsic Health Solutions, Enveric Biosciences, Enzolytics, Enzychem Lifesciences, Enzymatica, EOS Imaging, Epirium Bio, Equillium, Er-Kim, Erasca, Erytech, Esaote, ES Cell International, Espero Biopharma, ESSA Pharma, Esteve, EtectRx, Ethicann Pharmaceuticals, Eticann S.A.S. Zomac, Eton Pharmaceuticals, Etta Biotech, Eucure Biopharma, Eurofarma, Eurofins Genomics, European Commission, European Medical Contract Manufacturing, European Organization for Research and Treatment of Cancer, European Union, Eutilex, EV Biologics, Eve & Co, Event Cardio Group, Everest Medicines, Evergreen Theragnostics, Evgen Pharma, Evofem, Evoke Pharma, Evolus, Evonik Industries, Evotec, Ewopharma, Exacis Biotherapeutics, Exactech, Exact Imaging, Exact Sciences, Exact Therapeutics, Exactus, Exagen Diagnostics, Exalenz Bioscience, ExCellThera, Excelra, Exela Pharma Sciences, Exelixis, Exergen Medical, ExeVir Bio, EXMceuticals, Exosome, Exosome Diagnostics, Exothera, Expedeon, Experic, Experion Biotechnologies, ExpreS2ion Biotechnologies, Express Scripts, EyeCare Services Partners, Eyegate Pharmaceuticals, Eyegene, EyePoint Pharmaceuticals, EyeQ Vision, F-Star, F1 Oncology, Fabre Kramer Pharmaceuticals, Fabric Genomics, Factorial Diagnostics, Fagron, Fapon Biopharma, Fareva Holding, Farmacias Magistrales, Faron Pharmaceuticals, Federal Emergency Management Agency, FedMed, Feel Better, Feel Ventures, Fermentalg, Ferndale Pharma Group, Ferrer International, Ferring Pharmaceuticals, FibroGenesis, Fidelis Sustainability Distribution, Finch Therapeutics, Fine Foods & Pharmaceuticals N.T.M., Finorga, Fio, Firma Clinical Research, First Horizon Pharmaceuticals, First Nation Group, Five Prime Therapeutics, Flexion Therapeutics, Flexpoint Sensor Systems, Flextronics, Florida Pharmaceutical Products, Florida State University, Flowserve, Fluence Bioengineering, Fluidigm, Fluum, Foamix Pharmaceuticals, Focal, Food and Drug Administration (FDA), Forbion Capital Partners, ForDoz Pharma, Forge Biologics, Forsitech, Fortified Provider Network, Forty Seven, Fosun International, Fosun Pharmaceutical, Franklin Medical Center, Freeline Therapeutics, Fresenius Kabi Pharmaceuticals, Fresenius Medical Care, Fresno, Frontida BioPharm, FSD Pharma, Fujifilm, Fujifilm Diosynth Biotechnologies, Fujifilm medical systems, Fuji Pharma, Fujirebio Diagnostics, Full Genomes, Fuse Medical, Fusion Pharmaceuticals, G-Con, Galecto, Galen, Galenicum Health, Gallery Brands, Galmed Pharmaceuticals, Gamida Cell, Gamma Medica, Gastrologix, Gates Biomanufacturing Facility, GAVI Alliance, GB Sciences, GC Cell, Gebro Pharma, Gedeon Richter, GE Healthcare, Gelest, Gemini Therapeutics, Gen9, Genapsys, GeneNews, Genentech, Geneos Therapeutics, General Atomics, General Motors, Genesis Automation, GenesisCare, Gene Therapy Research Institution, Genetic Analysis, Genetic Technologies, Genialis, Genmab, Genome and Company, Genomics England, Genomind, Genomoncology, Genopis, Genovi Pharmaceuticals, Genpharm, Genprex, GenScript Biotech, GenScript ProBio, GenSpera, Gentex, GentiBio, Gentronix, Geocann, GeoVax, German Government, German Red Cross, German Red Cross Blood Donor Service, Germfree, Gerresheimer, Getinge, Gilead Sciences, Ginkgo BioWorks, GlaxoSmithKline, GL Brands, Glenmark Pharmaceuticals, Glide, Global Medical Solutions, Global Medical Supply, Global Orthopaedic Technology, Global Response Aid, Globus Medical, Gloryway, GlycoMimetics, Glycostem Therapeutics, Glycotope Biotechnology, Glytec, GNC, GNYHA Services, goBalto, Golden Valley Development, Golden Vine International, Good & Green, Goodwin Biotechnology, Government of Argentina, Government of Australia, Government of Bahrain, Government of Canada, Government of France, Government of Israel, Government of Japan, Government of Netherlands, Government of Ontario, Government of Serbia, Government of Singapore, Government of South Korea, Government of Switzerland, Government of The Philippines, Grace Fine Chemicals, Gracell Biotechnologies, Grail, Grand River Aseptic Manufacturing, Greater New York Hospital Association, Greene Street Pharmaceuticals, Greenlane Biogas, Greenlight Biosciences, Greenwich LifeSciences, Greiner Bio-One, Grid Therapeutics, Grifols, GroupHEALTH Benefit Solutions, Grunenthal, Grupo Ferrer, GSW Creative Corporation Canada, GT Biopharma, Guerbet, Guided Therapeutics, Guided Therapy Systems, Gulf Coast Pharmaceuticals, Gulf Coast Regional Blood Center, Gunze, GVS, Gynial, Gyros Protein Technologies, HaemaLogiX, Haematologic Technologies, Haemonetics, Hainan Sihuan Pharmaceutical, Hainan Visum Pharmaceutical, Haisco Pharmaceutical, Halberd, HalioDx, Halix, Halo Labs, Halyard Health, Hamilton Company, HanAll Pharmaceuticals, Hanfpost, Hangzhou Chance Pharmaceuticals, Hansen Medical, Hanuman Pelican, Harbour Biomed, Harpoon Therapeutics, Hartford HealthCare, Harvard Pilgrim Health Care, Harvard School of Public Health, Harvest One, Havn Life Sciences, Hawaii Medical, Health and Happiness Group, Health Care Originals, HealthPort, HealthTech Connex, HealthTrust, HealthTrust Purchasing Group, Healthy.io, Heidelberg Pharma, Helen F Graham Cancer Center, Helius Medical Technologies, Helix, Helomics, HemaCare, HemispheRx Biopharma, Hemogenyx, HemoMinas Foundation, Hempacco, Hempsana, Henry Schein, Herbolea Biotech, Heritage Cannabis, Heritage Pharmaceuticals, Hetero Labs, Heumann Pharma Generics, Hexo, Hibernation Therapeutics, High Desert Heart Institute, Highmark Blue Shield, High Tide Ventures, Hikma Pharmaceuticals, Hile Bio-Technology, Himed Hospital Management, HiMedia Laboratories, Histapharm, Histogenics, Hitachi, Hitachi Aloka Medical, Hitachi Chemical, HJB, HLH BioPharma Vertriebs, HMicro, Hoffmann La Roche, HollandPTC, Hollister-Stier Labs, Hollister Biosciences, Hongene Biotechnology, Hookipa Pharma, Horizon Discovery, Horizon Therapeutics, Hospira, Hoth Therapeutics, Hovione, HOYA Corporation, HR Pharmaceuticals, HTC ChemRar, HTG Molecular Diagnostics, HTL Biotechnology, Hualan Biological Bacterin, Humana, Humanigen, Human Longevity, Humavox, Hummingbird Bioscience, Hunan Xing Hang Rui Kang Bio-Technologies, Huntsman Cancer Institute, Hybrid Pharm, Hygio, Hyundai Pharmaceutical, I-mab, I-MED Pharma, IBA, Ibex Medical Analytics, iBio, iBiologics, iCAD, Ichnos Sciences, Icon, Iconovo, iCRYO Cryotherapy, ICT Health, IDEAYA Biosciences, Idorsia, IDT, IDT Biologika, IDx, iHear Medical, Ilera Therapeutics, Illumina, IlmixGroup, IMA, ImaginAb, Imagin Medical, Imanova, Imbio, ImClone Systems, Immatics Biotechnologies, Immedica, Immix Biopharma, Immune Design, ImmuneOncia Therapeutics, Immune Pharmaceuticals, Immune Therapeutics, ImmunityBio, ImmunoCellular Therapeutics, Immunogenesis, Immunome, Immunomedics, Immunomic, ImmunoPrecise Antibodies, ImmunOs Therapeutics, ImmunoTek Bio Centers, Immutep, Impact Cryotherapy, IMPACT Therapeutics, Impax Laboratories, Imperial College London, Implant Therapeutics, Impression Healthcare, Imprimis Pharmaceuticals, ImprimisRx, Imugene, In2Bones USA, IncellDx, Incepta Pharmaceuticals, Inceptua, Incyte, Indapta Therapeutics, Indica Labs, Indoco, Indus Pharma, InfectoPharm, Infex Therapeutics, Infinity BiologiX, Infinovo Medical, Information Technology for Translational Medicine, Infrared Cameras, Ingredion, Inhalation Sciences, Inhibrx, InMed Pharmaceuticals, INmune Bio, InnoBation, Innova Biosciences, Innovare, Innovasource, Innovate UK, Innovative Diagnostic Laboratory, Innovus Pharmaceuticals, Inovio, Inovio Pharmaceuticals, Inovytec, Instem, Instillo, Institut de Radiofarmacia Aplicada de Barcelona, Institute for Bioscience and Biotechnology Research, Institut Pasteur, Intalere, Integer Holdings, Integra LifeSciences, Integrated BioTherapeutics, Integrated Computer Solutions, Integrated DNA Technologies, Integrated Medical Systems, IntelGenx, Intellipharmaceutics, Interbiome, Intermountain Healthcare, International Isotopes, International Vaccine Institute (IVI), International Vitamin, Interpolymer/Zschimmer & Schwarz, Interrad Medical, Intersect ENT, Intralytix, IntraOp Medical, Intrexon, IntriCon, INVAP, Inventia Life Science, Invetech, Invibio Biomaterial Solutions, inviCRO, Invion, INVO Bioscience, Invotek Group, Ionetix, IonOpticks, Ion Torrent, Iovance Biotherapeutics, Ipca Laboratories, I Peace, iPharma, Ippox Foundation, Ipsen, IriSys, Iroko Pharmaceuticals, ISDIN, Island Garden, Isohelix, Isologic Innovative Radiopharmaceuticals, IsoTherapeutics, Isotopia Molecular Imaging, iSpecimen, Istari Oncology, Italian Government, ITEL, Item, ITEM Medical Technologies, Iteris, iThemba Laboratory, ITM Isotopen Technologien, ITW Pillar Technologies, Iveric Bio, ivWatch, iX Biopharma, Jacksonville Pharmaceuticals, Jaguar Health, Jamieson, Jana Care, JanOne, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Government, Jazz Pharmaceuticals, JDP Therapeutics, JEIL Pharmaceutical, Jenner Institute, JFE Engineering, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Medicine, Jiangsu Provincial Institute of Materia Medica, Jiangsu Tainuo, John Morley Foods, Johns Hopkins Medicine (JHM), Johns Hopkins University, Johnson & Johnson, Johnson Matthey, JRT Nurseries, JS Biosciences, Jubilant Hollisterstier, Jubilant Life Sciences, Julius Group, Jumpcan Pharmaceutical, Juno Therapeutics, Junshi Biosciences, Just Biotherapeutics, JuvenIL, K2M, Kadmon Pharmaceuticals, KAHR Medical, KA Imaging, Kalsec, Kamada, Kanabo Research, Kancera, Kane Biotech, Kaneka, KangStem Biotech, Kantaro Biosciences, Kapa Biosystems, Karolinska Development, Karolinska Institute, Karolinska University Hospital, Kate Farms, Kazmira, KBI BioPharma, Keck School of Medicine of USC, KEDPlasma, Kedrion Biopharma, Keio Center for Clinical Research (CCR), Kemwell BioPharma, Kensington Pharma, Kent Imaging, KeraFAST, Keryx Biopharmaceuticals, KeyBioScience, Keystone Heart, Key Tronic, KeyTronic, Khalifa Kush Enterprises, Khrysos Industries, Kiadis Pharma, Kindred Bio, Kindred Healthcare, Kindstar Globalgene Technology, Kinectrics, Kineta, Kinetic Dx, Kings College London, Kiniksa Pharmaceuticals, Kinova, Kintor, Kissei Pharmaceutical, Kitakyushu General Hospital, Kite Pharma, Kitov Pharma, Klaria, KMG International, Kneat, Knighton Foods, Knight Therapeutics, Know Labs, Kobe Kanagawa Eye Clinic, KoKo, Koushan Pharmed, Kowa Pharmaceuticals America, KRS Global Biotechnology, Kurin, Kuwait Government, KVK-Tech, KYE Pharmaceuticals, Kyowa Hakko Kirin Pharmaceuticals, Labcon, Labcyte, Laboratorios Adler, Laboratorios Bago, Laboratorios Farmaceuticos Rovi, Laboratorios SALVAT, LABORATORIOS SAVAL, Laboratory Corporation of America, LabStyle Innovations, Laccure, LakePharma, LamKap Bio Group, Lancet, Landrace Bioscience, Lannett, Lantheus Holding, Lantheus Medical Imaging, Lanzhou Ion Therapy, Laurus Labs, Lava Therapeutics, Laxisam, Leaf Biopharmaceutical, Lee's Pharmaceutical, Lee Health, Leica Biosystems, Leiden University, Leiters, Lentigen, Leon-nanodrugs, Leonhardt's Launchpads, Les Laboratoires Servier, Leukocare, LEXEO Therapeutics, LFB Group, LGC, LI-COR Biosciences, Libbs Farmaceutica, LIDDS, LifeArc, Lifehealthcare, LifeLiver, Lifeloc Technologies, LifeServe Blood Center, LifeSouth Community Blood Centers, Lifestyle Delivery Systems, Life Technologies, Ligand Pharmaceuticals, Lighthouse Imaging, Lighthouse Instruments, Lineage Cell Therapeutics, LineaRx, Lin International, Link-age Solutions, Linked Equipment, LION Eye Group, Lipidor, Lipomedix Pharmaceuticals, List Biological Laboratories, Livzon Pharmaceutical, LLamasoft, Lombard Medical Technologies, Lonza, Los Altos Pharmaceuticals, Louisiana State University, Lovell Government Services, LSNE Contract Manufacturing, LTS Lohmann Therapie-Systeme, Lubrizol, Lukare Medical, Lumara Health, Lumicks, Luminarie, Luminex, Lumos Pharma, Lundbeck, Lune Rise Farms, Luxoft, Luye Pharma Group, LV Prasad Eye Institute, Lyell Immunopharma, Lyfe Medical, Lygos, Lysogene, Maastricht University, Mabion, mAbXience, Maccabi Healthcare Services, Mackenzie Innovation Institute, Macrogen, Macrogenics, Maersk-Andersen, Magenta Therapeutics, MagicMed Industries, Magnetic Insight, Magnet Sales and Manufacturing, Magnolia Extracts, Magnolia Medical, Maitland Labs, MAJL Diagnostics, Major Health Partners, Mallinckrodt Pharmaceuticals, Mannin Research, ManRos Therapeutics, Maple Leaf Green World, Maplex Naturals, Maratek, Marathon Medical, Maren Cosmetics, Marianna Naturals, Marina Biotech, MarinHealth, Marinus Pharmaceuticals, Mars Petcare, Martindale Pharma, Maruho, Maryland Proton Therapy Center, Maryland State Medical Society, Masimo, MassMutual, MaSTherCell, Mast Therapeutics, Materialise, Mawson Infrastructure, Max Foundation, MaxiVAX, Mayne Pharma, MBioTeQ, McKesson, McMaster University, MD Anderson Cancer Center, Medac, Med Alliance, Medassets, MedCAD, Medcolcanna Organics, Medela, Medeor Therapeutics, Medexus Pharmaceuticals, MediaPharma, Medibio, Medicago, Medical Cannabis by Shoppers, Medical Developments International, Medical Marijuana, Medicines Patent Pool Foundation, Medicom, Medicure, Medidata Solutions, Medifocus, Medigen Biotechnology, MediGene, Mediheal Group of Hospitals, Medimetriks, MedImmune, Medinova, Medipath, MediPharm Labs, Medisca, Medivir, MediWound, Medizone International, Medline Industries, MedMira, Medovex, MedReleaf, Medtronic, Medx, MeiraGTx, Meito Sangyo, Mekics, Mel-Mont Medical, Melbourne Biotech, MellingMedical, Memorial Sloan Kettering Cancer Center, Memo Therapeutics, Meotec, Mercachem, Merck and Co, Merck KGaA, Merck Sharpe & Dohme, Mercury Plastics, Merge Healthcare, Meridian Medical Technologies, MESA Specialty Gases & Equipment, Mesoblast, Mespere LifeSciences, Metabolic Technologies, Metamark Genetics, Metaoptima Technology, Methapharm, Methodist Hospital Houston, Metro Orthopedics and Sports Therapy, Metuchen Pharmaceuticals, Mevion Medical Systems, Mexico Government, MGC Pharma, MGI Pharma, Microbix Biosystems, MicroCoat Biotechnologie, Microdrop, MicroGEM, MicroPort Scientific, Microsoft, Midatech, Midge Medical, MILabs, Milestone Scientific, Millar, Millipore, MilliporeSigma, Minapharm, Minaris Regenerative Medicine, MindChild Medical, Mindray Medical International, Mindset Pharma, Minerva Neurosciences, MiniFab, Ministry of Health, Ministry of Health (Brazil), Ministry of Health (Israel), Ministry of Health (Saudi Arabia), Ministry of Health (Turkey), Ministry of Health, Labor and Welfare, Ministry of Health and Prevention, Minneapolis Medical Research Foundation, Minomic, Minovia Therapeutics, Minute Molecular Diagnostics, MIP Diagnostics, Miravo Healthcare, MirCod, Misonix, Mission Bio, Mission Pharmacal, Mitani Sangyo, Mithra Pharmaceuticals, Mitsubishi Tanabe Pharma, Mitsui Norin, MMJ PhytoTech, MM Technology, Moberg Pharma, Mobidiag, MobileODT, Mobius Imaging, Mochida Pharmaceutical, Moderna Therapeutics, Modern Dental Group, Modus Health, Modus Therapeutics, Molecular Devices, Molecular Loop, Molecular Targeting Technologies, Moleculin Biotech, MolGen, MolMed, Mologen, Mologic, Molteni Farmaceutici, Momenta Pharmaceuticals, Monopar Therapeutics, Montagu Private Equity, Montefiore Health System, Montreal Cannabis Medical, MorphoSys, Morphotek, Motorika, Mountain Valley MD, Mount Sinai Health System, MPX International, MRIGlobal, MRI Interventions, MRM Proteomics, MR Solutions, MSD, MSD Animal Health, MTF Biologics, Mundipharma, Musculoskeletal Transplant Foundation, Mustang Bio, Mycenax Biotech, Mycovia Pharmaceuticals, Mydecine Group, Mylan Laboratories, Mylan Pharmaceuticals, MYM Nutraceuticals, MySugarWatch DuoPack, myTomorrows, n-Lorem Foundation, N1 Technologies, Nabriva Therapeutics, Naia Pharma, Nalu Bio, Namaste Technologies, Nanexa, Nano-X Imaging, Nanobiotix, NanoCarrier, Nanodigmbio, Nanoform, NanoPass Technologies, Nanotherapeutics, Nanowear, NantHealth, NantKwest, Narayana Nethralaya Foundation, Natera, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Green Biomed, National Healthcare Services (NHS), National Health Service, National Immunobiological Company, National Institute for Innovation in Manufacturing Biopharmaceuticals, National Institute of Allergy and Infectious Diseases
For full list of companies please contact us on email@example.com
Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.
The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Collaborative R&D
• Contract service
• Equity purchase
• Joint venture
• Royalty financing
• Spin out
• Sub license
Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.